UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008406
Receipt number R000009889
Scientific Title A double-blind cross-over study comparing the effects of single doses of fexofenadine, olopatadine, ketotifen fumarate and placebo on sedation in healthy Japanese subjects
Date of disclosure of the study information 2012/07/11
Last modified on 2013/01/11 10:55:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A double-blind cross-over study comparing the effects of single doses of fexofenadine, olopatadine, ketotifen fumarate and placebo on sedation in healthy Japanese subjects

Acronym

A study comparing the effects of anti histamine on sedation

Scientific Title

A double-blind cross-over study comparing the effects of single doses of fexofenadine, olopatadine, ketotifen fumarate and placebo on sedation in healthy Japanese subjects

Scientific Title:Acronym

A study comparing the effects of anti histamine on sedation

Region

Japan


Condition

Condition

Healthy male subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effects of single oral doses of fexofenadine and olopatadine, ketotifen fumarate on objective measures of daytime sleepiness, psychomotor performance and subjective assessments of sedation in healthy Japanese subjects.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sleepiness

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

fexofenadine

Interventions/Control_2

olopatadine

Interventions/Control_3

ketotifen fumarate

Interventions/Control_4

placebo

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male

Key inclusion criteria

- Those who have the ability to provide written informed consent to participate in the study.
- Healthy males aged between 20 and 40 years.
- Body weight between 50 and 100 kg, and a body mass index (BMI) between 18 and 32 kg/m2.

Key exclusion criteria

-Any anaphylaxis with fexofenadine, olopatadine or ketotifen fumarate.
-Any renal or hepatic disease requiring treatment.
-Any convulsive disease or disease requiring treatment.
-Any hereditary problem of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
-QT prolongation over 460 ms.
-Use of any medicine or health product that contains Saint John's wort within 7 days before dosing.
- Intake of fruit juice containing grapefruit juice or orange juice within 7 days before dosing.
- Participation in any other clinical reseach in the past 3 months.
- Donating over 200 ml of blood within the past 1 month or over 400 ml of blood within the past 3 months.
- Poorly controlled arterial hypertension (Systolic blood pressure >160mmHg and/or diastolic blood pressure >100mmHg)
- Positive HIV antibody, VDRL(quality), HBs antigen or HCV antibody.
- Positive drug screening.
- Any condition that, in the opinion of the investigator, would make the subject unsuitable for participation in the study.

Target sample size

16


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Kumagai

Organization

Kitasato university east hospital

Division name

Clinical trial center

Zip code


Address

2-1-1Asamizodai, Minami, Sagamihara, Kanagawa,

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kitasato University East Hospital

Division name

Clinical trial Center

Zip code


Address


TEL

042-748-9111

Homepage URL


Email



Sponsor or person

Institute

Clinical trial Center,Kitasato University East Hospital

Institute

Department

Personal name



Funding Source

Organization

Clinical trial Center,Kitasato University East Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2012 Year 04 Month 18 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 11 Day

Last modified on

2013 Year 01 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009889


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name